Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 6, 2003, Pages 1481-1492

  Ott, Elisabeth ^b,c   Nussmeier, Nancy A ^b,d   Duke, Peter C ^b,e   Feneck, Robert O ^b,f   Alston, R Peter ^e,g   Snabes, Michael C ⁱ   Hubbard, Richard C ⁱ   Hsu, Ping H ^a   Saidman, Lawrence J ^a,b,h,i   Mangano, Dennis T ^a,b  

^a Ischemia Research and Education Foundation   (United States)

^b McSPI Research Group   (United States)

^c UNIVERSITY OF MUNICH   (Germany)

^d TEXAS HEART INSTITUTE   (United States)

^e HEALTH SCIENCES CENTRE   (Canada)

^f ST THOMAS HOSPITAL   (United Kingdom)

^g ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^h STANFORD UNIVERSITY MEDICAL CENTER   (United States)

ⁱ PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; MORPHINE; OPIATE; PARACETAMOL; PARECOXIB; VALDECOXIB;

ADULT; AGED; ANALGESIA; ANXIETY; ARTICLE; BRONCHOSPASM; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENZYME INHIBITION; EXTUBATION; FATIGUE; FEMALE; FEVER; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPOTENSION; INSOMNIA; INTERMETHOD COMPARISON; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; NAUSEA; OLIGURIA; PATIENT CONTROLLED ANALGESIA; PERIPHERAL EDEMA; PLEURA EFFUSION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; SOMNOLENCE; STERNOTOMY; SURGICAL TECHNIQUE; TACHYCARDIA; TREATMENT PLANNING; VERTIGO; VOMITING; WOUND INFECTION;

EID: 0037635061     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00125-9     Document Type: Article

References (39)

1. Mueller XM, Tinguely F, Tevaeaeari HT, Revelly JP, Chiolero R, Von Segesser LK. Pain location, distribution, and intensity after cardiac surgery. Chest. 2000; 118:391-6.
2. Gust R, Pecher S, Gust A, Hoffmann V, Bohrer H, Martin E. Effect of patient-controlled analgesia on pulmonary complications after coronary artery bypass grafting. Crit Care Med. 1999;27:2218-23.
3. Garcia Rodriguez RL, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994:343:769-72.
4. Daniels SE, Grossman EH, Kuss ME, Talwalker S, Hubbard RC. A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus keterolac and placebo in a post-oral surgery pain model. Clin Ther. 2001:23:1018-31.
5. Camu F, Beecher T, Recker DP, Verburg KM. Valdecoxib, a COX-2 specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty. Am J Ther. 2002;9:43-51.
6. Desjardins P, Talwalker S. Preoperative administration of valdecoxib, a potent COX-2 specific inhibitor, provides effective postoperative analgesia. Anesthesiology. 2001;95:A-811.
7. Lipsky PE. Recommendations for the clinical use of cyclooxygenase-2-specific inhibitors. Am J Med. 2001;110:3S-5S.
8. Buttgereit F, Burmester GR, Simon LS. Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors. Am J Med. 2001;110:13S-9S.
9. Whelton A. Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors. Am J Med. 2001;110:33S-42S.
10. Catella-Lawson F, Crofford LJ. cyclooxygenase inhibition and thrombogenicity. Am J Med. 2001:110:28S-32S.
11. Hernandez-Diaz S, Garcia-Rodriguez LA. Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs. Am J Med. 2001:110:20S-7S.
12. Wideman GL, Keffer M, Beaver WT. Analgesic eficacy of a combination of hydrocodone with ibuprofen in postoperative pain. Clin Pharmacol Ther. 1999;65:66-76.
13. Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med. 1994;23:129-38.
14. Daut RL, Cleeland AS, Flannery RC. Development of the Wisconsin brief pain questionnaire to assess pain in cancer and other diseases. Pain. 1983:17:197-210.
15. Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Safety. 1994;10:93-102.
16. Mora Mangano CT, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A. Mangano DT, et al. Renal dysfunction following myocardial revascularization: risk factors, adverse outcomes and hospital resource utilization. Ann Intern Med. 1998;128:194-203.
17. Roach GW, Kanchuger M, Mora Mangano CT, Newman MF, Nussmeier NA, Wolman R, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med. 1996:335:1857-63.
18. Kennedy JW, Kaiser GC, Fisher LD. Multivariate discriminant analysis of the clinical and angiographic predicators of operative mortality from the collaborative study in coronary artery surgery (CASS). J Thorac Cardiovasc Surg. 1980;80:876-87.
19. Weissman C. Pulmonary function after cardiac and thoracic surgery. Anesth Analg. 1999;88:1272-9.
20. Kehlet H, Dahl JB. The value of "multimodal" or "balanced analgesia" in postoperative pain treatment. Anesth Analg. 1993;77:1048-56.
21. Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A. NSAIDS associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med. 1998;158:1108-12.
22. Page J, Henry D. Consumption of NSAIDS and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med. 2000;160:777-84.
23. Gibson FA. Reduce dose of NSAIDS in the elderly. Br J Anaesth. 1999;81:369-72.
24. Hynnienen MS, Cheng DC, Hossian IJ, Carroll J, Aumbhagavan SS, Yue R, et al. Non-steroidal anti-inflammatory drugs in treatment of postoperative pain after cardiac surgery. Can J Anaesth. 2000;47: 1182-7.
25. Rapanos T, Murphy P, Szalai JP, Burlacoff L, Lam-McCulloch J, Kay J. Rectal indomethacin reduces postoperative pain and morphine use after cardiac surgery. Can J Anaesth. 1999;46:725-30.
26. Lin JC, Swerc MF, Magovern JA. Non-steroidal anti-inflammatory drug-based pain control for iminimally invasive direct coronary artery bypass surgery. Heart Surg Forum. 1999;2:169-71.
27. Cannon GW, Breedveld FC. Efficacy of cyclooxygenase-2-specific inhibitors. Am J Med. 2001;110:6S-12S.
28. Mukherjee C, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001;286:954-9.
29. Marvin KA, Weir MR, Reicin A. Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. Circulation. 2001;104:2280-8.
30. White WB, Faich G. Celecoxib. a cyclooxygenase-2 specific inhibitor, is not associated with an increased risk of pro-thromboembolic events. Am J Cardiol. 2002;89:425-30.
31. Lichenstein SV, Ashe KA, el Dalati H, Cusimano RJ, Panos A, Slutsky AS. Warm heart surgery. J Thorac Cardiovasc Surg. 1991; 101:269-74.
32. Yau TM, Weisel RD, Mickle DA, Komeda M, Ivanov J, Carson S, et al. Alternative techniques of cardioplegia. Circulation. 1992;86:I1377-84.
33. Julia PL, Buckberg GD, Acar C, Partington MT, Sherman MP. Studies of controlled reperfusion after ischemia. XXI. Reperfusate composition: superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage. Importance of endogenous oxygen free radical scavengers in red blood cells. J Thorac Cardiovasc Surg. 1991;101:303-13.
34. Herskowitz A, Mangano DT. The inflammatory cascade: a final common pathway for perioperative injury? Anesthesiology. 1996;85:957-60.
35. The Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
36. Chesebro JH, Fuster V, Elveback LR, Clements IP, Smith HC, Holmes DR Jr, et al. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med. 1984;310: 209-14.
37. Mangano DT for the McSPI Research Group. Effects of acadesine on myocardial infarction, stroke and death following surgery: a meta-analysis of the five international randomized trials. JAMA. 1997;277: 325-32.
38. Jain KK. Evaluation of intravenous parecoxib for the relief of acute post-surgical pain. Expert Opin Investig Drugs. 2000;9:2717-23.
39. Mangano DT. Aspirin and mortality from coronary bypass surgery. N Engl J Med. 2002;347:1309-17.